Disappointing Results of Nonclinical PreIND Study for Ampios OA201
On February 14, 2024, groundbreaking nonclinical pre-IND enabling studies were concluded, evaluating the potential of Ampio's remarkable product, OA-201. Unfortunately, ...
© 2024 Stocks Today